Biological Evaluation of a Novel Tissue Engineering Scaffold of Layered Double Hydroxides (LDHs)

Bone Tissue Engineering (BTE) Composed of Three Main Parts: Scaffold, Cells and Signaling Factors. Several Materials and Composites Are Suggested as a Scaffold for BTE. Biocompatibility is One of the Most Important Property of a BTE Scaffold. in This Work Synthesis of a Novel Nanocomposite Including Layered Double Hydroxides (LDH) and Gelatin is Carried Out and its Biological Properties Were Studied. the Co-Precipitation (PH=11) Method Was Used to Prepare the LDH Powder, using Calcium Nitrate, Magesium Nitrate and Aluminum Nitrate Salts as Starting Materials. the Resulted Precipitates Were Dried. X-Ray Diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM) Analyses Were Used to Characterize the Synthesized Powders. the Results Demonstrated the Presence of Nanocrystals of Ca-LDH and Mg-LDH as Hexagonal and Layered Morphology. the Obtained Powders Were Composed to Gelatin Via Solvent Casting Method Then Freez Dried. the Scaffold Was Prepared Via Membrane Lamination Method from the Resulted Layers that Linked Together with Gelatin as Binder. in Order to Investigate the Scaffold Cytotoxicity MTT Assay Was Done with a Osteosarcoma Cell Line. No Toxic Response Was Observed in Specimens. as a Major Result, It Was Demonstrated that the Specimen Showed a Significant Cellular Response. Then Osteosarcoma Cells Were Cultured for 7-Day and 14-Day Extract of Powders. the Composites Osteoconductivity Was Investigate with Cells Alkaline Phosphatase Extraction. the Results Demonstrated that the Ca-LDH/gelatin Composite Scaffold Has a Good Potential for Bone Tissue Engineering Applications and Mg-LDH Specimen Has a Better Osteconductivity. © (2012) Trans Tech Publications

Neutrophil Gelatinase-Associated Lipocalin induces the expression of heme oxygenase-1 and superoxide dismutase 1, 2

Lipocalin-2 (Lcn2, NGAL) is a member of the lipocalin super family with diverse function such as the induction of apoptosis, the suppression of bacterial growth, and modulation of inflammatory response. Much interest has recently been focused on the physiological/pathological role of the lipocalin-2 that is considered to be a novel protective factor against oxidative stress. However, its precise biological roles in this protection are not fully understood. In this report we intended to test the effect of lipocalin-2 on the expression of heme oxygenase (1, 2) and superoxide dismutase (1, 2) which are two strong antioxidants. NGAL was cloned to pcDNA3.1 plasmid by using genetic engineering method. The recombinant vector was transfected to CHO and HEK293T to establish stable cell expressing NGAL and the expression of HO-1, 2 and SOD1, 2 were compared with appropriate controls byRT-PCR and western blot. On the other hand, expression of NGAL was suppressed by siRNA transfection in order to study the effect of lipocalin-2 on mentioned genes/proteins. The results showed that the expression of HO-1 and SOD 1, 2 enzymes were higher in cells expressing recombinant lipocalin-2 compared with the control cells. Although the expression of HO-1 was lower in NGAL silencing cells, the expression of SOD1 and SOD2 were higher. Our data suggest that NGAL is a potent inducer of HO-1 and somewhat SOD1 and SOD2 and it appears that part of antioxidant property of NGAL could be attributed to the induction of HO-1and SOD 1, 2. © Cell Stress Society International 2009

High-levelexpression of functional recombinant human coagulation factor VII in insect cells

Abstract: Recombinant coagulation factor VII (FVII) is used as a potential therapeutic intervention in hemophilia patients who produce antibodies against the coagulation factors. Mammalian cell lines provide low levels of expression, however, the Spodoptera frugiperda Sf9 cell line and baculovirus expression system are powerful systems for high-level expression of recombinant proteins, but due to the lack of endogenous vitamin K-dependent carboxylase, expression of functional FVII using this system is impossible. In the present study, we report a simple but versatile method to overcome the defect for high-level expression of the functional recombinant coagulation FVII in Sf9 cells. This method involves simultaneous expression of both human γ-carboxylase (hGC) and human FVII genes in the host. It may be possible to express other vitamin K-dependent coagulation factors using this method in the future. Keywords: Baculovirus; γ-carboxylase; Coagulation FVII; Factor VII; Insect cel

Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review

Immunoglobulin-A vasculitis (IgAV) is classically a childhood small-sized blood vessel vasculitis with predominant involvement of the skin. Gastrointestinal and joint manifestations are common in patients diagnosed with this condition. Nephritis, which is more severe in adults, constitutes the most feared complication of this vasculitis. The molecular bases underlying the origin of IgAV have not been completely elucidated. Nevertheless, several pieces of evidence support the claim that genes play a crucial role in the pathogenesis of this disease. The human leukocyte antigen (HLA) region is, until now, the main genetic factor associated with IgAV pathogenesis. Besides a strong association with HLA class II alleles, specifically HLA-DRB1 alleles, HLA class I alleles also seem to influence on the predisposition of this disease. Other gene polymorphisms located outside the HLA region, including those coding cytokines, chemokines, adhesion molecules as well as those related to T-cells, aberrant glycosylation of IgA1, nitric oxide production, neoangiogenesis, renin-angiotensin system and lipid, Pyrin and homocysteine metabolism, may be implicated not only in the predisposition to IgAV but also in its severity. An update of the current knowledge of the genetic component associated with the pathogenesis of IgAV is detailed in this review.Acknowledgements: RL-Mis supported by the Miguel Servet I programme of the Spanish Ministry of Economy and Competitiveness through the grant CP16/ 00033. FG is recipient of a Sara Borrell postdoctoral fellowship from the “Instituto Carlos III de Salud” at the Spanish Ministry of Health (Spain) (CD15/00095). SR-M is supported by funds from the RETICS Program (RIER) (RD16/0012/0009). FDC is supported by the Ramón y Cajal programme of the Spanish Ministry of Economy and Competitiveness through the grant RYC-2014-16458

SYNTHESIS, MICROSTRUCTURE AND MECHANICAL PROPERTIES OF Mg - 5Zn - 0.3Ca/nHA NANOCOMPOSITES

Recently, magnesium and its alloys have attracted great attention for use as biomaterial due to their good mechanical properties and biodegradability in the bio environment. In the present work, nanocomposites of Mg - 5Zn - 0.3Ca/ nHA were prepared using a powder metallurgy method. The powder of Mg, Zn and Ca were firstly blended, then four different mixtures of powders were prepared by adding nHA in different percentages of 0, 1, 2.5 and 5 %wt. Each mixture of powder separately was fast milled, pressed, and sintered. Then, the microstructure and mechanical properties of the fabricated nanocomposites were investigated. The XRD profile for nanocomposites showed that the intermetallic phases of MgZn2, MgZn5.31 and Mg2Ca were created after sintering and the SEM micrographs showed that the grain size of nanocomposite reduced by adding the nHA. The nano composite with 1wt. % nHA increased the density of Mg alloy from 1.73 g/cm3 to 1. 75 g/cm3 by filling the pores at the grain boundaries. The compressive strength of Mg alloy increased from 295MPa to 322, 329 and 318MPa by addition of 1, 2.5 and 5wt. % nHA, respectively

Mutations in Thalassemia Carrier Couples: The Importance of Prenatal Diagnostic Tests

Background: Thalassemia carrier couples play an important role in increasing thalassemia patients. The study of thalassemia genotypes in carrier couples is also effective in improving genetic counseling for them. The aim of this study was to investigate the prevalence of thalassemia mutations and genotypes in couples. Methods: This cross-sectional study was performed on 241 couples who were suspected of thalassemia from April 2018 to March 2020 in Lorestan province. Statistical analysis of data was performed using SPSS software 16.0 (SPSS Inc., Chicago, IL, USA). Online tools such as www.ithanet.eu/db/ithagenes and http://globin.bx.psu.edu/hbvar/menu.html were also used to match patients' mutations with known cases. Results: IVSII-1 (G>A), CD36-37 (-T), IVSI-110 (G>A), —Med, and alpha(3.7 )were the most common mutations in the beta and alpha genes, respectively. IVSII-1 (G>A) 130/13 (26.1), CD36-37 (-T) beta 0/beta (21.1), and IVSI-110 (G>A) beta 0/beta (10.3) genotypes were the most common in women. The frequency of these genotypes in men were 24.8, 28.6, and 12.8, respectively. Among alpha thalassemia carriers, the alpha(3.7)alpha/alpha alpha genotype had the highest frequency among women (3.7) and men (5.3). Alpha and beta-thalassemia were 15 and 13 times higher in related women and 18 and 9 times higher in related men than non-related ones, respectively. This difference was statistically significant (p < 0.001). In addition, 12.8 of fetuses were thalassemia major, 31.9 beta thalassemia minor, and 10.3 normal. Conclusions: Thalassemia screening in related couples plays an important role in reducing thalassemia major infants

Blood Coagulation Disorders Among the Iranian Population: a Systematic Review

Background: Blood coagulation disorders are one of the causes of mortality. Therefore, the study of coagulation disorders is also important. This systematic review was conducted to investigate blood coagulation disorders in the Iranian population. Methods: Searches in electronic databases such as Web of Science, PubMed, Scopus, SID, ProQuest, and Magiran from May 10, 1990 to May 10, 2019 were performed according to PRISMA guidelines. Cross-sectional, cohort, experimental, and case-control studies were included according to the inclusion criteria without gender and language restrictions. Results: After screening and selection, 14 studies were selected for data extraction. Accordingly, the most common blood coagulation disorder in the south of Iran was a defect in FXIII (599 of 1,165). C.559T>C (27 of 189) and c.562T>C (20 of 189) mutations had the highest frequency. The most common FXIII polymorphism among the Iranian Azerbaijanis was Val34Leu (203 of 410). The second most common coagulation disorder was FV Leiden (396 of 1,165). Then, c.1691G>A (151 of 396) was the most common mutation. Conclusions: This study shows that the most critical coagulation disorder among the Iranian population is FXIII deficiency and the most common mutation is c.562T>C. © 2023 Verlag Klinisches Labor GmbH. All rights reserved